Literature DB >> 11978748

Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants.

G Boehm1, M Lidestri, P Casetta, J Jelinek, F Negretti, B Stahl, A Marini.   

Abstract

BACKGROUND: The establishment of a balanced intestinal microflora which may protect against infection is desirable for the preterm infant.
OBJECTIVE: To investigate the effect of a preterm formula milk supplement consisting of oligosaccharides in similar proportions to human milk on the faecal flora and stool characteristics of preterm infants. STUDY
DESIGN: To resemble the effect of human milk, an oligosaccharide mixture consisting of 90% galacto-oligosaccharides and 10% fructo-oligosaccharides was used to supplement a standard preterm formula at a concentration of 10 g/l. This supplemented formula was studied in 15 preterm infants, and the results were compared with those found in 15 infants fed a formula supplemented with maltodextrin as placebo. A group fed fortified mother's milk was investigated as a reference group (n = 12). On four days during a 28 day feeding period (1, 7, 14, and 28), the faecal flora was investigated, and stool characteristics, growth, and possible side effects were recorded.
RESULTS: During the study period, the number of bifidobacteria in the group fed the oligosaccharide supplemented formula increased to the upper range of bifidobacteria counts in the reference group. The difference between the supplemented and non-supplemented groups was highly significant (p = 0.0008). The stool characteristics were also influenced by the supplement: the stool frequency after 28 days was significantly lower in the control group than in the oligosaccharide supplemented group (p = 0.0079) and the reference group (p < 0.0001). Over the study period, the stool consistency in the control group became harder, but remained fairly stable in the other two groups. There was no effect of the different diets on the incidence of side effects (crying, regurgitation, vomiting) or on weight gain or length gain.
CONCLUSION: Supplementing preterm formula with a mixture of galacto- and fructo-oligosaccharides at a concentration of 10 g/l stimulates the growth of bifidobacteria in the intestine and results in stool characteristics similar to those found in preterm infants fed human milk. Therefore prebiotic mixtures such as the one studied may help to improve intestinal tolerance to enteral feeding in preterm infants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978748      PMCID: PMC1721408          DOI: 10.1136/fn.86.3.f178

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  16 in total

1.  Analysis of high-molecular-weight oligosaccharides from human milk by liquid chromatography and MALDI-MS.

Authors:  B Finke; B Stahl; A Pfenninger; M Karas; H Daniel; G Sawatzki
Journal:  Anal Chem       Date:  1999-09-01       Impact factor: 6.986

Review 2.  Oligosaccharides in human milk and bacterial colonization.

Authors:  D S Newburg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000       Impact factor: 2.839

3.  Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract.

Authors:  M B Engfer; B Stahl; B Finke; G Sawatzki; H Daniel
Journal:  Am J Clin Nutr       Date:  2000-06       Impact factor: 7.045

4.  Clinical assessment of gestational age in the newborn infant.

Authors:  L M Dubowitz; V Dubowitz; C Goldberg
Journal:  J Pediatr       Date:  1970-07       Impact factor: 4.406

Review 5.  Biological functions of oligosaccharides in human milk.

Authors:  C Kunz; S Rudloff
Journal:  Acta Paediatr       Date:  1993-11       Impact factor: 2.299

Review 6.  Factors controlling the bacterial colonization of the intestine in breastfed infants.

Authors:  K Orrhage; C E Nord
Journal:  Acta Paediatr Suppl       Date:  1999-08

7.  Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months.

Authors:  M M Grönlund; H Arvilommi; P Kero; O P Lehtonen; E Isolauri
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-11       Impact factor: 5.747

Review 8.  The bifidogenic nature of chicory inulin and its hydrolysis products.

Authors:  M B Roberfroid; J A Van Loo; G R Gibson
Journal:  J Nutr       Date:  1998-01       Impact factor: 4.798

9.  Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns.

Authors:  H Sakata; H Yoshioka; K Fujita
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

Review 10.  Health benefits of non-digestible oligosaccharides.

Authors:  M B Roberfroid
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

View more
  59 in total

Review 1.  The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer.

Authors:  Melissa M Kaczmarczyk; Michael J Miller; Gregory G Freund
Journal:  Metabolism       Date:  2012-03-07       Impact factor: 8.694

2.  Genes involved in obesity: Adipocytes, brain and microflora.

Authors:  L Macia; O Viltart; C Verwaerde; M Delacre; A Delanoye; C Grangette; I Wolowczuk
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

3.  A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age.

Authors:  G Moro; S Arslanoglu; B Stahl; J Jelinek; U Wahn; G Boehm
Journal:  Arch Dis Child       Date:  2006-07-27       Impact factor: 3.791

4.  Cultivating healthy growth and nutrition through the gut microbiota.

Authors:  Sathish Subramanian; Laura V Blanton; Steven A Frese; Mark Charbonneau; David A Mills; Jeffrey I Gordon
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

5.  The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.

Authors:  Octavian Alexea; Vlad Bacarea; Núria Piqué
Journal:  United European Gastroenterol J       Date:  2015-10-30       Impact factor: 4.623

6.  Metabolism of fructooligosaccharides by Lactobacillus paracasei 1195.

Authors:  Handan Kaplan; Robert W Hutkins
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

Review 7.  Recent developments in understanding the mechanisms of food allergy.

Authors:  Zoe C Schmiechen; Katherine A Weissler; Pamela A Frischmeyer-Guerrerio
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

8.  A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids.

Authors:  Mark A Underwood; Nita H Salzman; Stephen H Bennett; Melissa Barman; David A Mills; Angela Marcobal; Daniel J Tancredi; Charles L Bevins; Michael P Sherman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

9.  Pseudo-outbreak of vancomycin-resistant-enterococcus (VRE) Colonization in a neonatal intensive care unit using spectra VRE surveillance medium.

Authors:  Rita M Gander; Dominick Cavuoti; Adnan Alatoom; Paul Southern; Debra Grant; Kathleen Salinas; Donna Gaffney; Jennifer MacKenzie; Linda Byrd
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

Review 10.  Microbial therapeutic interventions.

Authors:  Nicole G Grady; Elaine O Petrof; Erika C Claud
Journal:  Semin Fetal Neonatal Med       Date:  2016-04-25       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.